Curis
CRIS
#10237
Rank
A$22.55 M
Marketcap
A$1.74
Share price
-10.08%
Change (1 day)
-68.08%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.52. In 2024 the company made an earnings per share (EPS) of A-$10.57 an increase over its 2023 EPS that were of A-$13.57.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-45.27%
2024A-$10.57-22.06%
2023A-$13.57-26.25%
2022A-$18.4022.3%
2021A-$15.04-25.37%
2020A-$20.16-30.93%
2019A-$29.18-2.02%
2018A-$29.78
2016A-$67.69-10%
2015A-$75.21138.1%
2014A-$31.5940%
2013A-$22.56-25%
2012A-$30.0866.67%
2011A-$18.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
A$3.58-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.12-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.54-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$5.08-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.59-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.47-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$16.91 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA